Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
Bristol-Myers Squibb (United States) · Institute for Computer Aided Design
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
937
total citations
- FWCI
- 50.36
- Percentile
- 100%
- References
- 23
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- NS5A
- NS5B
- Hepatitis C virus
- Ribavirin
- Virology
- NS3
- Replicon
- Genotype
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.